维普期刊资源整合服务平台（V6.5）

43篇 您的检索式：作者名="Bukowski T"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Randomized phase Ⅲ trial of sorafenib in advanced renal cell carcinoma (RCC):Impact of crossover on survival (abst) 显示文摘	Eisen T Bukowski RM Staehler M	2006	Proc Am Soc Clin Oncol2006，24，：	1
2	Recombinant ob protein reduces feeding and body weight in the ob/ob mouse显示文摘	WEIGLE D S BUKOWSKI T R	1995	J Clin Invent1995，96，4：	1
3	Randomized phase Ⅲ trial of sorafenib in advanced renal cell carcinoma (RCC): Impact of crossover on survival显示文摘	Eisen T Bukowski RM Staehler M	2006	J Clin Oncol2006，24，：	1
4	Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropep-tide Y gene expression in ob/ob mice显示文摘	SCHWARTZ M W BASKIN D G BUKOWSKI T R	1996	Diabetes1996，45，4：	1
5	Using the DRASTIC System to Assess the Vulnerability of Ground Water to Pollution in Mined Areas of the Upper Silesian Coal Basin显示文摘	P Bukowski T Bromek l Augustyniak	2006	Mine Water and the Environment2006，25，：	1
6	Randomized phase Ⅲ trial of sorafenib in advanced renal cell carcinoma (RCC): Impact of crossover on survival 显示文摘	Eisen T Bukowski RM Staehler M	2006	J Clin Oncol2006，24，18：	1
7	Final results of the randomized phase Ⅲ trial of sorafenib in advanced renal cell carcinoma: Survival and biomarker analysis显示文摘	Bukowski RM Eisen T Szczylik C	2007	J Clin Oncol2007，25，18：	1
8	Randomized phaseⅢtrial of sorafenib in advanced renal cell carcinoma(RCC):Impact of crossover on survival显示文摘	Eisen T Bukowski RM Staehler M	2006	J clin oncol2006，24，18：	1
9	Fabry-Perot Interferometer in Brillouin Scattering Experiments显示文摘	Blachowicz T Bukowski R Kleszczewski Z	1996	Rev Sci Instrum1996，67，12：	1
10	Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma显示文摘	Motzer R J Hutson T E Tomczak P Michaelson M D Bukowski R M Oudard S	2009	J Clin Oncol2009，27，：	1
11	Randomized phase Ⅲ trial of sorafenib in advanced renal cell carcinoma (RCC):Impact of crossover on survival显示文摘	Eisen T Bukowski RM Staehler M	2006	J Clin Oncol2006，24，：	1
12	Helium dimer potential from symmetry-adapted perturbation theory calculations using large Gaussian geminal and orbital basis sets显示文摘	T Korona H L Williams R Bukowski	1997	J Chem Phys1997，106，：	1
13	Randomized phase Ⅲtrial of sorafenib in advanced renal cell carcinoma (RCC): Impact of crossover on survival显示文摘	EISEN T BUKOWSKI RM STAEHIER M	2006	J Clin Oncol2006，24，18：	1
14	Interleukin-2 in cancer therapy: uses and optimum management of adverse effects显示文摘	Mekhail T Wood L Bukowski R	2000	Bio Drugs2000，14，5：	1
15	Sorafenib in advanced clear- cell carcinoma 显示文摘	Escudier B Eisen T Bukowski RM	2007	N Engl J Med2007，356，2：	1
16	Specificity of leptin action on elevated blood glucose and hypothalamic neuropeptide Y gene expression in ob/ob mice显示文摘	Barker J L Baskin D G Bukowski T R	1996	Diabetes1996，45，：	1
17	Recombinant ob protein reduces feeding and body weight in the ob/ob mouse 显示文摘	Weigle D S Bukowski T R Foster D C	1995	J Clin Invest1995，96，4：	1
18	Augustyniak, mine water and the environment显示文摘	BUKOWSKI P BROMEK T	2006	Mine Water Environ2006，25，1：	1
19	Sunitinib versus interferon alfa in metastatic renal-cell earcinoma 显示文摘	Motzer R J Hutson T E Tomczak P Michaelson M D Bukowski R M Rixe O	2007	N Engl J Med2007，356，：	1
20	Interleukin-2 in canc-er therapy : uses and optimum management of adverse effects显示文摘	MEKHAIL T’WOOD L’BUKOWSKI R	2000	Bio Drugs2000，14，5：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示